Abstract
Exploring the cost-consequences and barriers to implementation of the Preferred Drug Initiative by a pharmacist in an Irish General Practice setting
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zenodo (CERN European Organization for Nuclear Research)
Paper Title
Journal
Date
